EUR/USD
1.19708
0.143%
Gold
5505.55
1.648%
Oil
64.263
1.472%
USD/JPY
153.229
-0.115%
GBP/USD
1.38200
0.092%
GBP/JPY
211.768
-0.007%
Real-time News
Market news: Tesla is accelerating its transformation from the electric vehicle sector to the robotics sector.Sunny Optical Technology (02382.HK) announced on the Hong Kong Stock Exchange that the Group expects its net profit attributable to shareholders in 2025 to be approximately RMB4.589 billion to RMB4.723 billion, representing a year-on-year increase of 70.0% to 75.0%. This is mainly attributed to: the promotion of high-end specifications for smartphone cameras, the improvement of the Groups product mix, the increase in the average selling price and gross profit margin of mobile phone lenses and mobile phone camera modules; and investment income of approximately RMB919 million from the transfer of equity in subsidiaries.Sunny Optical Technology (02382.HK) repurchased 15.84 million ordinary shares between January 8 and 28, and expects the companys profit attributable to shareholders to increase by approximately 70-75% year-on-year in 2025.On January 29th, Hengrui Medicine announced that its subsidiary, Shandong Shengdi Pharmaceutical Co., Ltd., recently received a "Drug Clinical Trial Approval Notice" from the National Medical Products Administration (NMPA) for HRS-7535 tablets, and will soon commence clinical trials. According to the "Drug Administration Law of the Peoples Republic of China" and relevant regulations, after review, the HRS-7535 tablets application, accepted on November 5, 2025, meets the relevant requirements for drug registration, and approval is granted for Phase III clinical trials. The intended indication is the treatment of chronic kidney disease.Sources say Alibaba’s new chip has attracted more than 400 customers.
